M. Fiona Shortt de Hernandez

The Nobel Prize in medicine goes to 3 scientists for work on peripheral immune tolerance Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi have won the Nobel Prize in medicine for their discoveries about peripheral immune tolerance.

BREAKING: Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi win the Nobel Prize in medicine for work on peripheral immune tolerance.

Visiting family in Berlin after working in Halle this week. The beauty of the Brandenburger Tor never fails to amaze me! #Berlin

Biontech will Konkurrenten Curevac übernehmen Das Pharmaunternehmen Biontech will den deutschen Konkurrenten Curevac übernehmen. Es gebe ein öffentliches Umtauschangebot für alle Aktien von Curevac, teilte Biontech in Mainz mit.

Das Pharmaunternehmen Biontech will den deutschen Konkurrenten Curevac übernehmen. Es gebe ein öffentliches Umtauschangebot für alle Aktien von Curevac, teilte Biontech in Mainz mit.

Great to be learning about the exciting new developments in AI for pharma at the Digital-Tech Pharma & AI conference in London this week!

It rained and poured this morning but what a day to run through VfB’s home stadium during the Stuttgart-Lauf 2025! #dfb #vfbstuttgart #stuttgartlauf #10K

Biontech: Neue Medikamente, neuer Vorstand 2026 will Biontech sein erstes Krebsmedikament auf den Markt bringen. Jetzt wird klar, wie die Mainzer dabei vorgehen.

2026 will Biontech sein erstes Krebsmedikament auf den Markt bringen. Jetzt wird klar, wie die Mainzer dabei vorgehen.

Ehrung für BioNTech-Mitgründer Türeci und Sahin Jurychef der Deutschen Nationalstiftung, Mirow, sprach von einem "leuchtenden Beispiel".

Ehrung für BioNTech-Mitgründer Türeci und Sahin #Nationalpreis #BioNTech

Pancreatic cancer mRNA vaccine — exciting clinical trial results BioNTech's pancreatic cancer mRNA vaccine candidate, cevumeran, has shown promising results in a phase 1 trial.

Newly published data from a phase 1 clinical trial on a #PancreaticCancer #mRNA #vaccine shows that patients whose cancer went into remission after receiving the vaccine remained cancer-free after three years.

Awardees of the IUPAC 2025 Distinguished Women In Chemistry or Chemical Engineering

Happy #InternationalWomensDay 🎉

#IUPAC 2025 Awards for Distinguished Women in #Chemistry 👩‍🔬 #ChemicalEngineering

Yu-Ju Chen
Stefanie Dehnen
Hemda Garelick
Marie-Claude Heuzey
Young-Shin Jun
Tanja Junkers
Zhang Lin
Zhimin Liu
Jane Catherine Ngila
Ah-Hyung Alissa Park
Vivian W.W. Yam
Xuehua Zhang

Happy #InternationalWomensDay! Today, we celebrate the brilliant women shaping the future of #chemistry. From research to mentorship, their impact is undeniable. Let’s break barriers, amplify voices, and create a more inclusive STEM community! Who inspires you? Tag them! #IWD #ChemInclusion

The summer call of our International PhD programme is open! 📢

Ready to advance your scientific career? If you're passionate about #RNAbiology, #Bioinformatics, or #Immunology, apply to our open calls and join our global community of over 200 #PhD students! 🌍

www.imb.de/phd

Robert-Koch-Postdoktorandenpreis für den Themenbereich Immunologie (€ 5.000) / Bewerbungsschluss: 14. März 2025

Die DGfI hat ein Vorschlagsrecht für den Robert-Koch-Postdoktorandenpreis im Bereich Immunologie.

Mehr Informationen unter: dgfi.org/preise/koch-...

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer Nature - In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited...

Exciting results from BioNTech in collaboration with Genentech for the treatment of pancreatic cancer using an mRNA-lipoplex vaccine. #RNASky rdcu.be/eb4Lj

Ran the annual London Winter Run 10K @WinterRunUK for Cancer Research UK @CR_UK yesterday! An amazing experience as always & this time together with 25,000 other participants! A record number!!!🏃‍♀️🏃🏃‍♂️

From breaking barriers to building the future - women and girls are shaping our world with discovery, innovation and courage. Let’s celebrate their brilliance and inspire the next generation!#WomenInScience #InternationalDayofWomenandGirlsinScience #ChemInclusion

Interested in undertaking a PhD in the transformative field #mRNA cancer vaccines? I have an earmarked #PhD scholarship available for an outstanding domestic student to join our team at UQ and @basemrna.bsky.social. If this sounds like you, get in touch.

study.uq.edu.au/study-option...

Bill Gates in Mainz: Star-Unternehmer besucht BioNTech Microsoft-Gründer Bill Gates war in dieser Woche in Mainz: Er besuchte das Unternehmen BioNTech.

merkurist.de/mainz/anfang...

We are looking for a postdoc to join the Knight Group! Interested in the interface of peptide and polymer chemistry with applications in therapeutics and nanomaterials? Send questions or an application with a cover letter, CV, and statement of previous research. #chempostdoc

www.knightgroupunc.org

Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning - Nature Biotechnology An integrated experimental and deep learning pipeline reveals cell-level targeting of nanocarriers in whole bodies.

Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning - @erturklab.bsky.social @hendrikdietz.bsky.social go.nature.com/4gNLjeC

Mit KI gegen Krebs: Wie Biontech zum zweiten Mal Medizingeschichte schreiben will Mit dem Covid-Impfstoff hat das Mainzer Unternehmen Biontech Milliarden Euro verdient. Nun setzen seine Gründer Uğur Şahin und Özlem Türeci dieses Geld ein, um an ihrem eigentlichen Lebenswerk zu arbeiten: den Krebs endgültig zu besiegen. Kann es dem Paar…

Mit dem Covid-Impfstoff hat das Mainzer Unternehmen Biontech Milliarden Euro verdient. Nun setzen seine Gründer Uğur Şahin und Özlem Türeci dieses Geld ein, um an ihrem eigentlichen Lebenswerk zu arbeiten: den Krebs endgültig zu besiegen. Kann es dem Paar gelingen?

A picture of the journal's front cover

Happy launch day everyone! We're really excited to share our first issue, which is now available to read online here www.nature.com/nrct/

Method of the Year 2024: spatial proteomics - Nature Methods Approaches for profiling the spatial proteome in tissues are the basis of atlas-scale projects that are delivering on their promise for understanding biological complexity in health and disease.

I could not be more thrilled to announce the Nature Methods @naturemethods.bsky.social Method of the Year is Spatial Proteomics! Please see our editorial as a roadmap to the fantastic content in this special issue! www.nature.com/articles/s41...

A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro A claudin5 binding peptide enhances transport across the blood-brain barrier by transiently permeabilizing tight junctions.

The blood-brain barrier can prevent therapeutic drugs from reaching the brain.

Researchers in #ScienceAdvances have identified a peptide that increases the barrier’s permeability, showing potential for more effective drug delivery to treat brain diseases. scim.ag/4jhnWf6

I made a starter pack for interesting people in the mRNA vaccines and therapeutics space. Message me if you want to be added. #RNAsky

go.bsky.app/VSHfBce